无法控制的喘和严重的COVID-19:一个潜在的双向风险分析
Stina Selberg1, Johanna Karlsson Sundbaum1, Anne Lindberg1
1Department of Public Health and Clinical Medicine, Umeå University, the OLIN and Sunderby Research Unit at Region Norrbotten, Umeå, Sweden.
Journal of asthma and allergy
|February 26, 2026
概括
控制不良的喘会增加严重的COVID-19风险. 反过来,COVID-19住院治疗会增加未来喘恶化的风险,这凸显了喘控制和COVID-19结果之间的双向关系.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 控制喘对于控制症状和预防不良结果至关重要.
- 新出现的证据表明,喘控制不良和严重的COVID-19之间存在联系.
- 对这种双向关系缺乏大规模研究.
研究的目的:
- 评估失控的喘是否是COVID-19住院和死亡的风险因素.
- 为了确定COVID-19流行期间喘控制是否发生了变化.
- 为了调查COVID-19住院是否会增加未来失控喘的风险.
主要方法:
- 分析了来自瑞典国家气道登记 (2014-2020) 的125,362名喘患者的队列.
- 用喘控制测试 (ACT) 评估喘控制,肺功能 (预测FEV1%) 和恶化的频率/严重程度.
- 数据包括到2022年12月的COVID-19住院和死亡率.
主要成果:
- 控制不良的喘 (ACT得分低,FEV1减少,频繁/严重恶化) 显著增加了COVID-19住院的风险.
- 控制得非常差的喘 (ACT <16),频繁和严重的恶化与COVID-19死亡率有关.
- 虽然喘控制指标相对稳定,但COVID-19住院治疗被确定为未来喘恶化的风险因素.
结论:
- 喘控制不良的所有方面都与患重症COVID-19的风险更高有关.
- 相反,COVID-19住院增加了未来喘恶化的风险.
相关概念视频
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
COPD: Management Using Bronchodilators and Corticosteroids
950
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
950


